Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Fridechickens prediction

<< Previous

Bullboard Posts

Next >>

Comment by Bigboypantson Mar 19, 2021 9:46pm

216 Views

Post# 32843970

RE:RE:RE:RE:RE:RE:RE:RE:RE:Fridechickens prediction

Get lost ! you are like the biggest baby with your posts. March isn't over and something tells me you are worried when the price goes up. This is a 2-4 dollar stock and it's making moves to get there. If you can't handle the PT then sell.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market